171 related articles for article (PubMed ID: 30875327)
1. PON1 arylesterase activity, HDL functionality and their correlation in malnourished children.
Mogarekar MR; Dhabe MG; Palmate MM
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):321-326. PubMed ID: 30875327
[TBL] [Abstract][Full Text] [Related]
2. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R
Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439
[TBL] [Abstract][Full Text] [Related]
4. Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
Lőrincz H; Harangi M; Oláh AV; Szabó GP; Fülöp P; Somodi S; Paragh G; Seres I
Pediatr Res; 2015 May; 77(5):703-9. PubMed ID: 25668223
[TBL] [Abstract][Full Text] [Related]
5. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
[TBL] [Abstract][Full Text] [Related]
7. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
8. High density lipoprotein subfractions and paraoxonase 1 in children.
Muchová J; Andrezálová L; Oravec S; Nagyová Z; Garaiova I; Ďuračková Z
Acta Biochim Pol; 2016; 63(3):555-63. PubMed ID: 27262841
[TBL] [Abstract][Full Text] [Related]
9. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
10. Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
Mahrooz A; Shokri Y; Variji A; Zargari M; Alizadeh A; Mehtarian E
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1166-1176. PubMed ID: 33579580
[TBL] [Abstract][Full Text] [Related]
11. Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.
Sutherland WH; de Jong SA; Walker RJ
Nephrol Dial Transplant; 2004 Jan; 19(1):75-82. PubMed ID: 14671042
[TBL] [Abstract][Full Text] [Related]
12. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
[TBL] [Abstract][Full Text] [Related]
13. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
14. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
15. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
16. Postprandial Paraoxonase 1 Activity Following Consumption of Recommended Amounts of Mixed Meals in Healthy Males.
Kameyama N; Maruyama C; Kotani K; Caccavello R; Gugliucci A; Matsui S; Araki R; Maruyama T
J Atheroscler Thromb; 2016; 23(2):225-32. PubMed ID: 26447089
[TBL] [Abstract][Full Text] [Related]
17. Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs.
Rossi G; Kuleš J; Rafaj RB; Mrljak V; Lauzi S; Giordano A; Paltrinieri S
Res Vet Sci; 2014 Oct; 97(2):318-24. PubMed ID: 25104322
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood.
Gugliucci A; Numaguchi M; Caccavello R; Kimura S
Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935
[TBL] [Abstract][Full Text] [Related]
19. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
20. Activity of paraoxonase 1 and lipid profile in healthy children.
Sumegová K; Nagyová Z; Waczulíková I; Zitnanová I; Duracková Z
Physiol Res; 2007; 56(3):351-357. PubMed ID: 16792468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]